Editorial companion

What stands out

Intuit slipped ahead of tonight’s earnings while Moderna jumped after Wolfe Research upgraded the drugmaker on a melanoma vaccine read, and Bloomberg framed both moves as emblematic of two very different market behaviors. One is a steady software company trading on earnings cadence, the other is a biotech leaping on clinical headlines and analyst optimism. For investors, the clip is a reminder that some stocks move because of fundamentals and cadence, others move because a single trial or note rewrites sentiment for a day or more.